Keyphrases
Anticancer Treatment
50%
Breath Analysis
25%
Breath Sampling
50%
Complete Response
25%
Computed Tomography
25%
Current Response
25%
Disease Control
50%
Disease Monitoring
25%
Early Identification
25%
Early Recognition
25%
Exhaled Breath
25%
Exhaled Breath Analysis
100%
Gas Chromatography-mass Spectrometry
25%
Gas Chromatography-mass Spectrometry Analysis
25%
Lack of Response
25%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Lung Cancer
50%
Monitoring System
25%
Nanoarrays
50%
Nanomaterials
25%
Oncologists
25%
Partial Response
50%
Patient Care
25%
Progressive Disease
50%
Quick Recognition
25%
Response Evaluation Criteria in Solid Tumors (RECIST)
75%
Response Monitoring
100%
Response to Therapy
50%
Response to Treatment
100%
Sensor Analysis
25%
Sensor Array
25%
Stable Disease
100%
Surrogate Marker
25%
Systemic Therapy
25%
Treatment Efficacy
25%
Treatment Failure
50%
Tumor Analysis
25%
Tumor Response
25%
Volatile Organic Compounds
25%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
12%
Disease
100%
Disease Marker
12%
Lung Cancer
100%
Nanomaterial
12%
Neoplasm
12%
Solid Malignant Neoplasm
37%
Volatile Organic Compound
12%
Biochemistry, Genetics and Molecular Biology
Anticancer
40%
Breathing
100%
Computer Assisted Tomography
20%
Gas Chromatography-Mass Spectrometry
40%
Mass Spectrometry
20%
Immunology and Microbiology
Breathing
100%
Computer Assisted Tomography
20%
Gas Chromatography Mass Spectrometry
40%
Mass Spectrometry
20%